IsoRay (ISR) Shares Up 7.7%
IsoRay, Inc. (NYSEAMERICAN:ISR) shares shot up 7.7% during trading on Tuesday . The company traded as high as $0.44 and last traded at $0.42. 679,593 shares traded hands during mid-day trading, an increase of 284% from the average session volume of 176,778 shares. The stock had previously closed at $0.39.
A number of brokerages have commented on ISR. HC Wainwright set a $1.00 price objective on IsoRay and gave the company a “buy” rating in a report on Thursday, February 14th. Zacks Investment Research downgraded IsoRay from a “hold” rating to a “sell” rating in a research report on Wednesday, February 13th.
IsoRay (NYSEAMERICAN:ISR) last released its earnings results on Tuesday, February 12th. The healthcare company reported ($0.02) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.02). The company had revenue of $1.90 million for the quarter, compared to the consensus estimate of $1.76 million.
IsoRay Company Profile (NYSEAMERICAN:ISR)
IsoRay, Inc, through its subsidiary, IsoRay Medical, Inc, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma.
Featured Story: Why is total return important?
Receive News & Ratings for IsoRay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IsoRay and related companies with MarketBeat.com's FREE daily email newsletter.